rxstat › Shortages › Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria (Boostrix) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Sep 17, 2026

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria has no current shortage reported in Canada. It has been in shortage before; the history is below.

A vaccine used to help protect against diphtheria, tetanus, and whooping cough.

Products affected
0 / 1
Reports on file
3

Shortage history

2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
BOOSTRIX
2.5MCG 20UNIT 8MCG 8MCG 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended Aug 12, 2026 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended May 15, 2023 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria is classified under “BACTERIAL VACCINES” (ATC J07AX).

Recent changes

Common questions

What is Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria used for?

A vaccine used to help protect against diphtheria, tetanus, and whooping cough.

When will Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria be back in stock in Canada?

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria has no active shortage; supply is normal per Health Canada reports.

Why is Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (bacterial vaccines)

Menveo (Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Gr…) No current shortage Prevnar (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) Discontinued 0 of 1 reported products affected Capvaxive (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) No current shortage Hiberix (Haemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate) Discontinued 0 of 1 reported products affected Menjugate (Meningococcal Group C Oligosaccharide Corynebacterium Diphth…) Discontinued 0 of 2 reported products affected Menomune-A/C/Y/W-135 (Meningococcal Polysaccharide Antigen Group A C W-135 Y) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.